Tandem Diabetes Care (TNDM) Leases (2019 - 2025)
Historic Leases for Tandem Diabetes Care (TNDM) over the last 7 years, with Q3 2025 value amounting to $98.4 million.
- Tandem Diabetes Care's Leases rose 1255.36% to $98.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $98.4 million, marking a year-over-year increase of 1255.36%. This contributed to the annual value of $85.3 million for FY2024, which is 283.06% down from last year.
- As of Q3 2025, Tandem Diabetes Care's Leases stood at $98.4 million, which was up 1255.36% from $98.4 million recorded in Q2 2025.
- In the past 5 years, Tandem Diabetes Care's Leases registered a high of $126.7 million during Q2 2022, and its lowest value of $15.1 million during Q1 2021.
- For the 5-year period, Tandem Diabetes Care's Leases averaged around $83.4 million, with its median value being $89.4 million (2023).
- In the last 5 years, Tandem Diabetes Care's Leases soared by 124922.73% in 2021 and then tumbled by 2811.83% in 2023.
- Tandem Diabetes Care's Leases (Quarter) stood at $27.5 million in 2021, then skyrocketed by 302.23% to $110.6 million in 2022, then decreased by 20.64% to $87.8 million in 2023, then dropped by 2.83% to $85.3 million in 2024, then increased by 15.31% to $98.4 million in 2025.
- Its Leases stands at $98.4 million for Q3 2025, versus $98.4 million for Q2 2025 and $101.0 million for Q1 2025.